COSMOS HEALTH INC (COSM) Fundamental Analysis & Valuation

NASDAQ:COSM • US2214133058

Current stock price

0.3262 USD
+0 (+0.4%)
At close:
0.3249 USD
0 (-0.4%)
After Hours:

This COSM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. COSM Profitability Analysis

1.1 Basic Checks

  • COSM had negative earnings in the past year.
  • COSM had a negative operating cash flow in the past year.
  • COSM had negative earnings in 4 of the past 5 years.
  • In the past 5 years COSM always reported negative operating cash flow.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of COSM (-26.68%) is worse than 82.00% of its industry peers.
  • With a Return On Equity value of -80.15%, COSM is not doing good in the industry: 73.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -26.68%
ROE -80.15%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

  • COSM has a worse Gross Margin (11.41%) than 73.00% of its industry peers.
  • In the last couple of years the Gross Margin of COSM has declined.
  • COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. COSM Health Analysis

2.1 Basic Checks

  • COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • COSM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, COSM has more shares outstanding
  • Compared to 1 year ago, COSM has a worse debt to assets ratio.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • COSM has an Altman-Z score of -2.14. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.14, COSM is doing worse than 85.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.55 indicates that COSM is somewhat dependend on debt financing.
  • COSM has a Debt to Equity ratio of 0.55. This is comparable to the rest of the industry: COSM outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC6.51%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • COSM has a Current Ratio of 0.99. This is a bad value and indicates that COSM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • COSM has a worse Current ratio (0.99) than 74.00% of its industry peers.
  • COSM has a Quick Ratio of 0.99. This is a bad value and indicates that COSM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.84, COSM is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.84
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. COSM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 68.03% over the past year.
  • Looking at the last year, COSM shows a small growth in Revenue. The Revenue has grown by 6.69% in the last year.
  • The Revenue has been growing slightly by 6.52% on average over the past years.
EPS 1Y (TTM)68.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.57%
Revenue 1Y (TTM)6.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%37.86%

3.2 Future

  • COSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.85% yearly.
  • Based on estimates for the next years, COSM will show a very strong growth in Revenue. The Revenue will grow by 33.72% on average per year.
EPS Next Y56.41%
EPS Next 2Y36.34%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue Next Year17.73%
Revenue Next 2Y34.26%
Revenue Next 3Y33.72%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. COSM Valuation Analysis

4.1 Price/Earnings Ratio

  • COSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COSM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • COSM's earnings are expected to grow with 27.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.34%
EPS Next 3Y27.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COSM Dividend Analysis

5.1 Amount

  • No dividends for COSM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COSM Fundamentals: All Metrics, Ratios and Statistics

COSMOS HEALTH INC

NASDAQ:COSM (3/30/2026, 8:00:01 PM)

After market: 0.3249 0 (-0.4%)

0.3262

+0 (+0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-18
Earnings (Next)04-10
Inst Owners4.1%
Inst Owner Change17.72%
Ins Owners32.05%
Ins Owner Change17.62%
Market Cap11.39M
Revenue(TTM)59.79M
Net Income(TTM)-18.54M
Analysts82.86
Price TargetN/A
Short Float %0.7%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.49%
Min Revenue beat(2)-17.28%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)-8.02%
Min Revenue beat(4)-17.28%
Max Revenue beat(4)2.29%
Revenue beat(8)2
Avg Revenue beat(8)-6.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-3500%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.71
BVpS0.66
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.68%
ROE -80.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.41%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.57%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.84
Altman-Z -2.14
F-Score3
WACC6.51%
ROIC/WACCN/A
Cap/Depr(3y)584.69%
Cap/Depr(5y)410.56%
Cap/Sales(3y)5.71%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.57%
EPS Next Y56.41%
EPS Next 2Y36.34%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue 1Y (TTM)6.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%37.86%
Revenue Next Year17.73%
Revenue Next 2Y34.26%
Revenue Next 3Y33.72%
Revenue Next 5YN/A
EBIT growth 1Y30.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.44%
OCF growth 3YN/A
OCF growth 5YN/A

COSMOS HEALTH INC / COSM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COSMOS HEALTH INC?

ChartMill assigns a fundamental rating of 1 / 10 to COSM.


What is the valuation status of COSMOS HEALTH INC (COSM) stock?

ChartMill assigns a valuation rating of 1 / 10 to COSMOS HEALTH INC (COSM). This can be considered as Overvalued.


Can you provide the profitability details for COSMOS HEALTH INC?

COSMOS HEALTH INC (COSM) has a profitability rating of 0 / 10.


How financially healthy is COSMOS HEALTH INC?

The financial health rating of COSMOS HEALTH INC (COSM) is 0 / 10.